Shuli Kulak Investigates Tomorrow’s Therapies Today Dr. Shuli (Roditi) Kulak’s ’05S, ’12E, ’17SB passion for science was discovered at a young age. “I found that I liked studying biology. As a kid, I’d read biology textbooks and go through the questions for fun,” she said with a laugh. After spending her freshman year at the…
Nine Undergraduates Recognized for Exceptional Academic Achievements
Eleven Yeshiva University (YU) undergraduate science students are spending the summer doing research with top scientific scholars at the university’s Albert Einstein College of Medicine in the Bronx.
Ten faculty members at Albert Einstein College of Medicine were honored at a special academic convocation Oct. 9, during which they were invested in newly endowed, named professorships made possible by major philanthropic contributions to the college of medicine.
Solomon Moshe, MD, professor of neurology, of pediatrics, and of neuroscience at Albert Einstein College of Medicine, was recently awarded the Jan Evangelista Purkyne Honorary Medal from the Academy of Sciences of the Czech Republic in recognition of his outstanding scientific achievements in the biomedical sciences.
Twelve Yeshiva University (YU) undergraduate science students are taking advantage of an exciting opportunity. They are spending the summer doing research with top scientific scholars at the university’s Albert Einstein College of Medicine (AECOM) in the Bronx. It is one of two programs that allow undergraduates with interest in science to participate in ongoing research projects.
Nathan Kahn, founder and CEO of Empire Resources Inc., in Fort Lee, N.J., has been elected to the Board of Overseers for Yeshiva University’s Albert Einstein College of Medicine.
Empire Resources is a public company with offices in North America, Europe and Australia. The Company distributes and manufactures aluminum products for sale to a wide array of industries for use in consumer products, automobiles, packaging, and housing materials.
Susan Band Horwitz, Ph.D., Distinguished Professor and co-chair of the Department of Molecular Pharmacology and the Falkenstein Professor of Cancer Research at the Albert Einstein College of Medicine of Yeshiva University, has been elected to the Institute of Medicine.
A third of the world’s people are infected with tuberculosis, and someone new is infected every second. TB is notoriously hard to treat, requiring a course of multiple antibiotics over six to nine months. Many people don’t complete the full course of treatment, which leads to increasing antibiotic resistance against the disease.
Albert Einstein College of Medicine’s 48th annual commencement will take place at Lincoln Center’s Avery Fisher Hall on Wednesday, May 31st, at 2:00 p.m. Dr. Irwin Merkatz, professor and chair of obstetrics & gynecology and women’s health at Einstein, will deliver the commencement address. He is celebrating his 25th anniversary this year at the helm of Einstein’s ob/gyn department.